A Study of GNC-038, a Tetra-specific Antibody, in Participants With R/R Non-Hodgkin Lymphoma
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Non Hodgkin Lymphoma
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: N/AIntervention Model: Sequential AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04606433
- Collaborators
- SystImmune Inc.
- Investigators
- Principal Investigator: Jianxiang Wang Hematology Hospital, Institute of Hematology, Chinese Academy of Medical Sciences Principal Investigator: Junyuan Qi Hematology Hospital, Institute of Hematology, Chinese Academy of Medical Sciences
Get Well Soon